It is clear that the costs associated with the Supreme Court ruling on Medicaid expansions will be a difficult and contentious topic. Some claim that the ruling will do very little to the spending projection or even create savings. Some estimate that spending will increase dramatically, possibly by $100 billion …
Some policymakers have difficulty understanding competition’s role in health care. There is a historical reason: With a legacy of third-party micromanagement, something like Medicare Part D—a program where about 1,100 drug plans compete for enrollees—is remarkably foreign. Several analysts cite this program as a marked success for competition in health …
